CL2004000931A1 - Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo. - Google Patents

Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo.

Info

Publication number
CL2004000931A1
CL2004000931A1 CL200400931A CL2004000931A CL2004000931A1 CL 2004000931 A1 CL2004000931 A1 CL 2004000931A1 CL 200400931 A CL200400931 A CL 200400931A CL 2004000931 A CL2004000931 A CL 2004000931A CL 2004000931 A1 CL2004000931 A1 CL 2004000931A1
Authority
CL
Chile
Prior art keywords
almidon
dissolve
modified
active agent
oral cavity
Prior art date
Application number
CL200400931A
Other languages
English (en)
Inventor
John Fadden Neema Mahesh David
Original Assignee
Warner Lambert Company Llc Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Company Llc Soc filed Critical Warner Lambert Company Llc Soc
Publication of CL2004000931A1 publication Critical patent/CL2004000931A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Grain Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Dental Preparations (AREA)

Abstract

UNA PELICULA CONSUMIBLE ADAPATADA PARA ADHERIRISE Y DISOLVERSE EN LA CAVIDAD ORAL DE UN ANIMAL DE SANGRE CALIENTE INCLUYENDO LOS SERES HUMANOS, QUE COMPRENDEN UN ALMIDON MODIFICADO, UN AGENTE FARMACEUTICAMENTE ACTIVO, Y OPCIONALMENTE AL MENOS UN POLIMERO HIDROSOLUBLE.
CL200400931A 2003-05-02 2004-04-30 Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo. CL2004000931A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46733903P 2003-05-02 2003-05-02

Publications (1)

Publication Number Publication Date
CL2004000931A1 true CL2004000931A1 (es) 2005-01-07

Family

ID=33418443

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400931A CL2004000931A1 (es) 2003-05-02 2004-04-30 Pelicula consumible adaptada para adherirse y disolverse en la cavidad bucal que comprende un almidon modificado y un agente farmaceuticamente activo.

Country Status (19)

Country Link
US (1) US20040247648A1 (es)
EP (1) EP1622595A1 (es)
JP (1) JP2006525308A (es)
CN (1) CN1784218A (es)
AR (1) AR044131A1 (es)
AU (1) AU2004233744A1 (es)
BR (1) BRPI0409463A (es)
CA (1) CA2523372A1 (es)
CL (1) CL2004000931A1 (es)
CO (1) CO5640073A2 (es)
GT (1) GT200400085A (es)
MX (1) MXPA05010422A (es)
PA (1) PA8601801A1 (es)
PE (1) PE20050175A1 (es)
RU (1) RU2005129309A (es)
TW (1) TW200503786A (es)
UY (1) UY28304A1 (es)
WO (1) WO2004096193A1 (es)
ZA (1) ZA200507205B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191302A1 (en) 2003-03-28 2004-09-30 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US8999372B2 (en) * 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
US20040131662A1 (en) 2003-11-12 2004-07-08 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US9561182B2 (en) * 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
BRPI0415741B1 (pt) 2003-11-07 2013-07-23 composições de tabaco e métodos de fabricação de uma composição de tabaco
DE102004002951A1 (de) * 2004-01-21 2005-08-11 Wella Ag Verfahren zur Herstellung haarfestigender Produkte in Folienform
PL2486942T3 (pl) 2004-11-24 2019-05-31 Meda Pharmaceuticals Inc Kompozycje zawierające azelastynę oraz sposoby ich stosowania
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
CA2612179C (en) * 2005-06-17 2016-08-02 Aft Pharmaceuticals Limited A pharmaceutical composition comprising loratadine and its use to treat patients with upper respiratory mucosal congestion
DE102005033943A1 (de) * 2005-07-20 2007-02-22 Hexal Ag Nicht-ausspuckbarer, oraler, schnell-zerfallender Film für ein Neuroleptikum
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
IL175338A0 (en) * 2006-05-01 2006-09-05 Biota Ltd Orally administrable films and preparation thereof
US20070293582A1 (en) * 2006-06-05 2007-12-20 Malcolm Hill Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
TW200816985A (en) * 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
US20070292481A1 (en) * 2006-06-16 2007-12-20 Hoffman Andrew J Packaging of Food Products with Pullulan Films
US20080152761A1 (en) * 2006-12-20 2008-06-26 Shiji Shen Packaging of Food Products with Pullulan Films
US20070298078A1 (en) * 2006-06-27 2007-12-27 Harrison Michael D Water Soluble Article for Imparting Dietary Fiber to Bottled Water
DE102006061287A1 (de) * 2006-12-22 2008-06-26 Lts Lohmann Therapie-Systeme Ag Eßbare folienförmige Zubereitung mit Cola-Geschmack
US20090011115A1 (en) * 2007-03-13 2009-01-08 Foss Carter D Edible Pullulan Films Containing Flavoring
US20080274252A1 (en) * 2007-04-12 2008-11-06 Hoffman Andrew J Pullulan film containing sweetener
US20090004254A1 (en) * 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
KR20100095581A (ko) * 2007-12-11 2010-08-31 노파르티스 아게 다-영역 필름
US20110114657A1 (en) * 2009-11-13 2011-05-19 Nygaard Leann M Beverage container holder and edible film package assembly
JP2012031164A (ja) * 2010-07-06 2012-02-16 Teika Seiyaku Kk フィルム状製剤
BR112013009255B1 (pt) * 2010-10-08 2021-02-23 R.P. Scherer Technologies, Llc composição sólida de vacina oral de dissolução rápida
US20130052234A1 (en) * 2011-08-25 2013-02-28 Purebrands LLC Edible strips
CN102836144A (zh) * 2012-09-28 2012-12-26 天津市聚星康华医药科技有限公司 一种去氧肾上腺素口腔速溶膜及其制备方法
HK1225624A1 (zh) 2013-07-31 2017-09-15 Bluepharma - Industria Farmaceutica, S.A. 口腔可分散膜
CN104530489B (zh) * 2015-02-05 2017-07-07 湖南尔康制药股份有限公司 一种速溶于水的淀粉成膜组合物
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
CN104983732B (zh) * 2015-05-28 2018-05-04 华润三九医药股份有限公司 一种布洛肾素那敏片及其制备方法
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
EP3416619A2 (en) * 2016-02-18 2018-12-26 Immune Therapeutics, Inc. Method for inducing a sustained immune response
CN111565716B (zh) 2017-09-08 2023-06-09 因斯格尼斯疗法有限公司 使用地匹福林的方法
WO2020180608A1 (en) 2019-03-01 2020-09-10 Insignis Therapeutics, Inc. Dipivefrin orally disintegrating tablet formulations
KR102221453B1 (ko) * 2019-07-19 2021-03-02 한국프라임제약주식회사 저분자 콜라겐 펩타이드 및 천연추출복합물을 포함하는 구강점막부착형 필름 조성물 및 이를 이용하여 제조된 구강점막부착형 필름
CN117653610B (zh) * 2023-09-28 2024-07-05 海南卓科制药有限公司 一种硝酸甘油片及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1142325A (en) * 1965-05-14 1969-02-05 Higham Stanley Russell Means for administering drugs
US4197289A (en) * 1975-12-15 1980-04-08 Hoffmann-La Roche Inc. Novel dosage forms
US4562020A (en) * 1982-12-11 1985-12-31 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for producing self-supporting glucan film
JPS60219238A (ja) * 1984-04-14 1985-11-01 Hayashibara Biochem Lab Inc 徐崩性プルラン含有成形物とその製法
DE3630603A1 (de) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
JPH0739508B2 (ja) * 1986-11-11 1995-05-01 株式会社林原生物化学研究所 プルラン・ポリエチレングリコ−ル会合物とその製造方法並びに用途
US5047244A (en) * 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
US5354551A (en) * 1989-10-14 1994-10-11 Desitin Arzneimittel Gmbh Oral and dental hygiene preparation
DE4018247A1 (de) * 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
JP3232488B2 (ja) * 1992-08-20 2001-11-26 株式会社林原生物化学研究所 プルラン高含有物とその製造方法並びに用途
US5411945A (en) * 1992-08-29 1995-05-02 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pullulan binder and its uses
US20030211136A1 (en) * 1998-09-25 2003-11-13 Neema Kulkarni Fast dissolving orally consumable films containing a sweetener
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US20020131990A1 (en) * 2000-11-30 2002-09-19 Barkalow David G. Pullulan free edible film compositions and methods of making the same
US6660292B2 (en) * 2001-06-19 2003-12-09 Hf Flavoring Technology Llp Rapidly disintegrating flavored film for precooked foods
US20030118653A1 (en) * 2001-07-06 2003-06-26 Lavipharm Laboratories Inc. Quick dissolving oral mucosal drug delivery device with moisture barrier coating
US6656493B2 (en) * 2001-07-30 2003-12-02 Wm. Wrigley Jr. Company Edible film formulations containing maltodextrin
WO2003030881A1 (en) * 2001-10-12 2003-04-17 Kosmos Pharma Glucan based film delivery systems
CA2473970C (en) * 2001-10-12 2013-05-28 Monosolrx Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20030099691A1 (en) * 2001-11-16 2003-05-29 Susan Lydzinski Films containing starch
CA2411889A1 (en) * 2001-11-16 2003-05-16 National Starch And Chemical Investment Holding Corporation Films containing starch

Also Published As

Publication number Publication date
PE20050175A1 (es) 2005-03-21
US20040247648A1 (en) 2004-12-09
AR044131A1 (es) 2005-08-24
CN1784218A (zh) 2006-06-07
BRPI0409463A (pt) 2006-05-02
MXPA05010422A (es) 2005-11-04
UY28304A1 (es) 2004-11-30
GT200400085A (es) 2005-03-03
EP1622595A1 (en) 2006-02-08
ZA200507205B (en) 2006-11-29
TW200503786A (en) 2005-02-01
JP2006525308A (ja) 2006-11-09
RU2005129309A (ru) 2006-05-10
CA2523372A1 (en) 2004-11-11
PA8601801A1 (es) 2004-11-26
CO5640073A2 (es) 2006-05-31
WO2004096193A1 (en) 2004-11-11
AU2004233744A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
PA8601801A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
PA8601401A1 (es) Peliculas consumibles por via oral que se disuelven rapidamiente, que contienen un edulcorante
HRP20060147B1 (hr) Terapijski sustav s kontroliranim otpuštanjem za nazalnu primjenu
UY28431A1 (es) Peliculas que se disuelven por via oral
AR052854A1 (es) Metodo para reducir la inflamacion del tejido oral utilizando extracto de magnolia
AR090677A2 (es) Preparacion farmaceutica que contiene oxicodona y naloxona
CL2008000893A1 (es) Composición para el cuidado bucal que comprende una cantidad efectiva de un aminoácido básico y un agente antibacteriano; uso en el tratamiento antibacteriano de la cavidad bucal.
BRPI0506305A (pt) artigos e métodos de tratamento da pele
BR0112054A (pt) Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR029655A1 (es) Mejoras en formulaciones en pasta
CR7500A (es) Formas de dosificacion de azitromicida con efectos secundarios reducidos
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
ES2160163T3 (es) Composiciones farmaceuticas a base de derivados de la clase de los taxanos.
UY25544A1 (es) Forma de dosificación de nefazodona
AR048050A1 (es) Formas de administracion masticables, no comprimidas, dosificadas individualmente
ES2125734T3 (es) Utilizacion de un 2-amino-alcano-1,3-diol para frenar la caida de los cabellos y/o inducir y estimular su crecimiento.
ATE347358T1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
AR052855A1 (es) Composiciones para el cuidado bucal que contienen un extrato de eucalyptus
AR038698A1 (es) Ambroxol para el tratamiento de estados dolorosos en la cavidad bucal y faringea
ES2156215T3 (es) Utilizacion de un conjugado en el tratamiento y/o diagnostico de enfermedades inflamatorias.
AR057474A1 (es) Composiciones de donepezil gelificado y metodos para la fabricacion y utilizacion de las mismas
PA8615501A1 (es) Formulaciones farmaceuticas transdermicas
EP1586312A4 (en) MEANS FOR THE SOLUTION OF TOOTH AND TOOTH CARIES